![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces its participation in the 2022 International Safe Transit Association (ISTA) Forum TempPack trade show April 11-13 in San Diego, Calif. The organisation’s Director of Research and Development, Bill Mayer, is a member of the ISTA Pharma Committee and will speak at the event.
“ISTA does important work globally to advance the field of temperature controlled performance packaging,” said David Williams, President of Peli BioThermal. “We are grateful for the opportunity to contribute to this work alongside industry peers and customers of temperature controlled solutions.”
For more than a year, the ISTA Pharma Committee and a group of end users and solutions providers came together to develop a best practices white paper on Ambient Temperature Profiles (ATPs). Mayer and Carolyn Williamson, President of Parenteral Supply Chain, LLC, led the group through the writing process and will present the paper on April 12 at 2 p.m. in the session titled “Ambient Temperature Profile Best Practice Paper.” The presentation will cover currently available industry ATPs, creating and defending an ATP, and how to characterise and compare ATPs.
Mayer will also participate in a panel discussion at 4 p.m. on the same day focusing on industry sharing with lane data. In addition to Mayer’s participation, Kai Goellner, Principal Product Development Engineer at Peli BioThermal, will share his insights on sustainability in a panel discussion on April 13 at 11:15 a.m. Goellner is responsible for Peli BioThermal’s award-winning sustainability work and white paper titled “An Environmental Impact Comparison of Packaging Methods in the Cold Chain Industry,” which compares the environmental impact of single-use and reusable shippers.
